Clinical Trial Update: Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating etoposide for recurrent or metastatic breast cancer; the current status is not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Etoposide (Etoposide)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN